{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae XL 1,25 Dihydroxyvitamin D",
        "LIAISON\u00ae XL 1,25 Dihydroxyvitamin D Control Set",
        "LIAISON\u00ae XL 1,25 Dihydroxyvitamin D Calibration Verifiers"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K141463",
    "Predicate Device Reference 510(k) Number(s)": [
        "K014030",
        "K132515"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG",
        "JJX"
    ],
    "Summary Letter Date": "November 12, 2014",
    "Summary Letter Received Date": "November 13, 2014",
    "Submission Date": "May 30, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1825",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "1,25 Dihydroxyvitamin D"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA Plasma",
        "Lithium Heparin Plasma",
        "SST Serum"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium Heparin tube",
        "Serum separator tube (SST)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Three-step sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator",
        "Calibration verifier",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON XL 1,25 Dihydroxyvitamin D CLIA assay, controls, and calibration verifiers for quantitative determination of 1,25 dihydroxyvitamin D on LIAISON XL Analyzer",
    "Indications for Use Summary": "Intended for quantitative determination of 1,25 dihydroxyvitamin D in serum, EDTA and lithium heparin plasma in adults, to assess vitamin D sufficiency; assay controls and calibration verifiers intended for monitoring assay performance and verifying calibration range on LIAISON XL Analyzer",
    "fda_folder": "Clinical Chemistry"
}